Home
RVAC Medicines

RVAC Medicines Market Share Analysis for June 2026

rvac medicines

Industry: N/A

Domainrvacmed.com

Year Founded2021

Employees51 - 200

Annual Revenue$1M - $2M

RVAC Medicines

RVAC Medicines (including company regionals)

rvacmed.com

See more website traffic and engagement information

RVAC Medicines Revenue up to June 2026 is 1M - 2M

revenue generated by RVAC Medicines top domains

RVAC Medicines top domains revenue over 3 years

Revenue for RVAC Medicines top domains

rvacmed.com1M - 2M

See more with Sales Intelligence

Total visits to RVAC Medicines's top domains

Understand RVAC Medicines market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

rvacmed.com2.7K

See more with Sales Intelligence

Avg. visit duration in RVAC Medicines's top domains

Analyze RVAC Medicines engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

rvacmed.com--

See more with Sales Intelligence

Avg. pageviews on RVAC Medicines's top domains

See how RVAC Medicines keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

rvacmed.com1.07

See more with Sales Intelligence

RVAC Medicines top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by RVAC Medicines

These are the website technologies, by industry, used by RVAC Medicines top domains

Advertising (1)

PubMatic

Content Management System (1)

Odoo

Conversion & Analytics (1)

CNZZ

Email Services (1)

Microsoft Exchange Online

More Technologies

3

See all

News & Signals from RVAC Medicines

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRVAC Medicines is developing solutions to construct messenger RNA manufacturing and analytics capabilities in Singapore.A month before this partnership, RVAC Medicines and A*STAR agreed to develop solutions to construct messenger RNA (mRNA) manufacturing and analytics capabilities in Singapore.

NewsRVAC Medicines partnered with University of Pennsylvania on Mar 17th '23.RVAC Medicines (US), Inc., a messenger RNA (mRNA) technology company with its global headquarters in Singapore, today announced the collaboration under a Sponsored Research Agreement with the University of Pennsylvania (" Penn ") focused on the discovery and development of mRNA vaccines that can modulate the body's normal immune response as possible treatments for certain autoimmune diseases and allergic conditions.

NewsGenscriptprobio partners with RVAC Medicines.Dr. Brian Min, CEO of GenScript ProBio said, “ProBio is delighted to enter into this strategic partnership with RVAC Medicines.